PainChek expanding into UK market
PainChek Limited (ASX:PCK) CEO Philip Daffas provides an overview of the company, discussing its recent agreement with Nourish Care to expand into the UK market.
Watch Now
PainChek® is the world’s first regulatory-cleared medical device for the assessment of pain, enabling bestpractice pain management for people living with pain in any environment, from those who cannot reliably self-report their pain, those who can, and for those whose ability to self-report their pain fluctuates.
The PainChek® app is available on smartphones and tablets and combines PainChek’s AI pain assessment tool, which intelligently automates the multidimensional pain assessment process, with the Numerical Rating Scale (NRS). This hybrid functionality allows accurate, consistent pain assessment at the point of care, and for care to be considered in PainChek’s detailed reporting suite, PainChek® Analytics.
Globally, PainChek® has attained regulatory clearance as a medical device in Australia, Canada, the European Union, New Zealand, Singapore, Malaysia, and the United Kingdom, with FDA review in the United States currently in progress. PainChek® has contracts with over 1,000 aged care facilities, with more than 5,000,000 digital pain assessments conducted to date, and is trusted by thousands of nurses, carers, and clinicians.
Using PainChek®, facilities can:
PainChek Limited (ASX:PCK) CEO Philip Daffas provides an overview of the company, discussing its recent agreement with Nourish Care to expand into the UK market.
Watch Now
A snapshot of the stocks on the move, featuring PainChek (ASX:PCK), Chimeric Therapeutics (ASX:CHM) and Torque Metals (ASX:TOR).
Watch Now
Philip Daffas, CEO & Managing Director, PainChek (ASX:PCK) develops mobile medical applications intended to provide pain assessment for people who cannot communicate with their carers.
Watch Now
Philip Daffas - CEO & Managing Director - PainChek (ASX:PCK) develops mobile medical applications intended to provide pain assessment for people who cannot communicate with their carers.
Watch Now
Philip Daffas - CEO & MD - PainChek is transforming pain management by using facial recognition and artificial intelligence to detect pain.
Watch Now